Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Samsung Electronics Shares Jump on HBM4 Mass Production Report 
Trump Administration Plans Chip Tariff Exemptions for Big Tech Amid AI Data Center Push 
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision 
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions 
Treasury Wine Estates Shares Surge After U.S. Dispute Settlement and Earnings Upgrade 
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins 
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible 
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal 
Salesforce Workforce Reduction Affects Fewer Than 1,000 Roles Amid Ongoing Restructuring 
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances 
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing 
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning 
TAMPA, Fla., Feb. 16, 2018 -- United Consortium Ltd. (OTC PINK:UCSO), an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Block Chain, Technology, Digital Media and the Emerging Cannabis Space, today announced that it has completed the process to upgrade its stock listing on OTC Markets to “Current Information”.
UCL Chairman and Chief Executive Officer Scott Gallagher stated, “While the process of removing the stop sign took longer than expected, we’re pleased to become a reporting Company on OTC Markets as we enter 2018.” Gallagher continued, “We can now focus our energy on the pending launch of our PHR Block Chain on March 15th. We’ll be hosting an investor conference call after the market closes on March 1st to discuss the launch of our personal health records block chain as well as provide additional information regarding the forward moving plans for our wholly owned subsidiary Block Chain, Inc.”
About United Consortium Ltd. (UCL)
UCL is an acquisition and development Company focused on creating shareholder value by identifying and monetizing opportunities in Technology, Internet, New Media and the Emerging Cannabis Space. The Company is headquartered in Tampa, Florida. The most current information about the Company can be found on OTCMarkets.com or by visiting the Company's website at www.UCLVentures.com.
Forward-Looking Statements
This release contains forward-looking statements that relate to future events or United Consortium Ltd. (UCL's) future performance or financial condition. Any statements that are not statements of historical fact, such as the statements above and including statements containing the words "plans," "anticipates," "expects" and similar expressions, should also be considered to be forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results and involve a number of risks and uncertainties. Actual results may differ materially from those in the forward-looking statements as result of a number of factors, including those described from time to time in United Consortium Ltd.’s filings with the Securities and Exchange Commission, OTC Markets or statement on the Companies websites. United Consortium Ltd. And all of its subsidiary companies undertakes no duty to update any forward-looking statements made herein.
Contact Information
For additional information contact:
Scott Gallagher
727-417-7807
